Gambling, tobacco, alcohol, drugs, and online gaming are industries that pose risks to individual and social health. Companies in this sector have a responsibility to balance immediate business with social ramifications.


Purdue Pharma Pleads Guilty to Criminal Charges for Opioid Sales

The Justice Department announced an $8 billion settlement with the company. Members of the Sackler …

1 year, 11 months

Instagram bans influencers from getting paid to promote vaping and guns

Facebook is also working on ways content creators comply with policies around alcohol or diet suppl…

2 years, 9 months

Federal prosecutors launch criminal probe of opioid makers, distributors

Federal prosecutors have reportedly opened a criminal investigation into whether pharmaceutical com…

2 years, 10 months

Trump Retreats From Flavor Ban for E-Cigarettes

Advisers say the president pulled back from proposed restrictions intended to curb teenage vaping a…

2 years, 10 months

E-cigarette giant Juul suspends sales of all fruity flavors ahead of looming US ban

Juul says the suspension does not affect mint, menthol and tobacco flavors.

2 years, 11 months

Four drug companies reach a last-minute $260 million opioid settlement with two Ohio counties

Four drug companies reached a last-minute legal settlement over their role in the opioid addiction …

2 years, 11 months

Gov. Baker defends decision to temporarily ban vaping products

by: Erica Ponte Posted: / Updated: BOSTON, Mass. (WPRI) - Governor Charlie Baker is doubling down o…

3 years

Walmart Stops Selling E-Cigarettes

Vaping-related lung illnesses have been on the rise, and federal and state health departments are i…

3 years

Purdue Pharma, Maker of OxyContin, Files for Bankruptcy

The filing is a centerpiece of an agreement to settle thousands of cases against the company for it…

3 years


Johnson & Johnson
Address High Drug Pricing via New Strategy

Recent ire has surfaced a number of financial and reputational risks to Johnson and Johnson resulting from from high priced pharmaceuticals.

$157.5 million supporting